Pharmacogenetics
Main - Science - Biology - Genetics - Genomics - Pharmacogenetics
| Latest news for this category: |
11/20/2008
Lilly Funding GPPC Study on Pharmacogenetics (GenomeWeb News)
GenomeWeb Daily News You are not logged in. Existing subscribers login here . New to GenomeWeb Daily News? Register quickly here for your free subscription.
MORE INFO
|
11/23/2008
Pearland’s Wu earnsM.D. Anderson honor (Pearland Journal)
Xifeng Wu, M.D., Ph.D., Pearland resident and professor of epidemiology in the Division of Cancer Prevention and Population Sciences at The University of Texas M. D. Anderson Cancer Center, is the recipient of the Julie and Ben Rogers Award for Excellence in Research for 2008.
MORE INFO
|
11/14/2008
Genetic disease treatments and pharmacogenetics: From scientific discovery to medical delivery (EurekAlert!)
( American Society of Human Genetics ) ASHG will host a press briefing session to highlight some of the top research presentations at the society's 58th Annual Meeting that report findings on important breakthroughs in the successful treatment of disease through novel genetic therapies and treatments, as well as new pharmacogenetics research findings that provide insights into appropriate drug ...
MORE INFO
|
11/20/2008
Clinical Data Participates in MAb IMPACT Meeting to Improve Clinical Efficacy of Monoclonal Antibodies for Cancer ... (Business Wire via Yahoo! Finance)
NEWTON, Mass.----PGxHealth®, a division of Clinical Data, Inc. , today announced its participation in the international mAb IMPACT meeting which is focused on IMProving ACTivation of the FCGR3A pathway for optimizing the treatment of cancer.
MORE INFO
|
11/16/2008
Genome-wide Association Scan For Genetic Determinants Of Warfarin Dose (Science Daily)
A growing number of geneticists are using genome-wide association studies (GWAS) to systematically search for and identify single nucleotide polymorphisms (SNPs), which are single base changes in the human DNA sequence that can cause differences in genetic characteristics. GWAS may also detect genes that are associated with a particular health condition, or with variation in patient response to ...
MORE INFO
|
11/07/2008
Cabernet Pharmaceuticals And Lilly Form Pharmacogenetics Alliance To Help Deliver Tailored Therapeutics To Patients (PharmaceuticalOnline)
Cabernet Pharmaceuticals, Inc. and Eli Lilly and Company today announced an alliance to further integrate pharmacogenetics into Lilly's drug-development efforts.
MORE INFO
|
11/07/2008
NC-based Cabernet Pharma and Eli Lilly team on pharmacogenetics (TechJournal South)
DURHAM, NC - Cabernet Pharmaceuticals Inc. and Eli Lilly & Co. (NYSE:LLY)are teaming to integrate pharmacogenetics into Lilly's drug development efforts.
MORE INFO
|
11/12/2008
Warnex Reports Third Quarter 2008 Results (CCNMatthews via Yahoo! Finance)
LAVAL, QUEBEC-- - Warnex Inc. today announced financial results for the third quarter ended September 30, 2008.
MORE INFO
|
11/11/2008
Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies (Centre Daily Times)
Affymetrix, Inc. (Nasdaq:AFFX) today announced the DMET(TM) Plus Premier Pack, the most comprehensive method for standardizing drug metabolism studies. The DMET (Drug Metabolism Enzymes and Transporters) Plus Panel features the most biologically relevant content identified by key opinion leaders from industry and academia in a cost-effective format. The DMET Plus Panel contains markers in all ...
MORE INFO
|
11/11/2008
Affymetrix Announces New Cost-effective Product for Standardizing Drug Metabolism Studies (Business Wire via Yahoo! Finance)
SANTA CLARA, Calif.----Affymetrix, Inc. today announced the DMET™ Plus Premier Pack, the most comprehensive method for standardizing drug metabolism studies. The DMET Plus Panel features the most biologically relevant content identified by key opinion leaders from industry and academia in a cost-effective format.
MORE INFO
|
|
| American Medical Association - Provides examples, scenarios, implications, definitions, and the economics of pharmacogenetics.DNAVision: Pharmacogenetic Studies - DNAVision helps pharmaceutical companies and clinical research organizations effectively integrate pharmacogenetics into their drug development program and thus deliver safer, more effective products to the market more quickly.National Institute of General Medical Sciences - Provides information on the institute's pharmacogenetics research network . Includes links to program announcements, news and events, and resources.An Overview of Pharmacogenetics - Provides the history, technology, and application of pharmacogenetics.Pharmacogenetics - Publish research papers and articles on genetic determinants of response to drugs and other chemicals in humans and animals. Table of contents, author guidelines, editorial board and subscription information.Pharmacogenetics - Information from Wikipedia on this field which is generally regarded as the study or clinical testing of genetic variation that gives rise to differing response to drugs.Pharmacogenetics of Anticancer Agents Research Group - PAAR - Identify and evaluate polymorphisms in drug metabolizing enzymes, transporters, or targets relevant to anticancer agents. Includes publications, training, and related links.Pharmocogenetics Knowledge Base - Integrated resource about how variation in human genetics leads to variation in response to drugs.UCSF Pharmacogenetics of Membrane Transporters Project - Conduct research and a series of integrated studies to elucidate the pharmacogenetics of membrane transport proteins. Includes information on personnel, publications, training, and available data.
|
Advertise in frame below:
Prayer is not an extra option nor is it a last resort when all other methods have failed. When man works, man works. But when man prays, God works!
Pharmacogenetics
Site map|Categories|Site map pages
|
|